GDTC

CytoMed Therapeutics Limited

HealthcareBiotechnologySGUSDPeers →Country macro →

$0.99

LiveJun 24, 2026

Market cap

$11.71M

52w range

0.68 – 3.68

P / E

—

EPS

—

Volume

44.48K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on CytoMed Therapeutics Limited’s valuation

○

Sell-side estimates and price targets skew heavily to US large-caps. We don't have consensus data for this issuer yet.